Generic cancer drug put to the test
Disease control
Completed
This study tested if a new generic version of the drug azacitidine works the same in the body as the existing brand-name version (Onureg). It involved 32 adults with a type of blood cancer called acute myeloid leukemia (AML) who were in remission. The main goal was to see if the …
Phase: PHASE1 • Sponsor: Hikma Pharmaceuticals LLC • Aim: Disease control
Last updated Mar 30, 2026 14:31 UTC